Education
About Us
Working with TipRanks
Follow Us
Evotec (GB:0IRF)
LSE:0IRF
0IRF Stock Chart & Stats
Day’s Range― - ―
52-Week Range€4.90 - €14.62
Previous CloseN/A
Volume41.80K
Average Volume (3M)51.42K
Market Cap
€1.05B
Enterprise Value€1.31B
Total Cash (Recent Filing)€111.63M
Total Debt (Recent Filing)€227.21M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Apr 17, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding177,763,520
10 Day Avg. Volume63,174
30 Day Avg. Volume51,423
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.20
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€12.80Price Target Upside131.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Bulls Say, Bears Say
Bulls Say
Business RecoveryPotential upside exists upon business recovery and as focus assets shift to later stages of development.
Debt ManagementDespite the net debt leverage ratio reaching 4.3x, management remains confident about meeting upcoming covenants.
Bears Say
Financial PerformanceThe net debt leverage ratio reached 4.3x, partly due to worsening EBITDA, indicating additional net debt reduction is needed.
Market UncertaintyThere is uncertainty over the timing of clarity on Evotec's 2025+ trajectory, with a risk that no guidance will be provided soon.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.02% Insiders
8.87%
Mutual Funds
<0.01% Other Institutional Investors
83.99% Public Companies and
Individual Investors
0IRF FAQ
What was Evotec’s price range in the past 12 months?
Evotec lowest share price was €4.90 and its highest was €14.62 in the past 12 months.
What is Evotec’s market cap?
Evotec’s market cap is €1.05B.
When is Evotec’s upcoming earnings report date?
Evotec’s upcoming earnings report date is Apr 17, 2025 which is in 12 days.
How were Evotec’s earnings last quarter?
Evotec released its earnings results on Nov 06, 2024. The company reported -€0.22 earnings per share for the quarter, missing the consensus estimate of -€0.11 by -€0.11.
Is Evotec overvalued?
According to Wall Street analysts Evotec’s price is currently Undervalued.
Does Evotec pay dividends?
Evotec does not currently pay dividends.
What is Evotec’s EPS estimate?
Evotec’s EPS estimate is >-0.01.
How many shares outstanding does Evotec have?
Evotec has 177,763,520 shares outstanding.
What happened to Evotec’s price movement after its last earnings report?
Evotec reported an EPS of -€0.22 in its last earnings report, missing expectations of -€0.11. Following the earnings report the stock price went down -13.406%.
Which hedge fund is a major shareholder of Evotec?
Currently, no hedge funds are holding shares in GB:0IRF
---
Evotec Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.98%
12-Months-Change
Fundamentals
Return on Equity
-16.25%
Trailing 12-Months
Asset Growth
-11.70%
Trailing 12-Months
Company Description
Evotec
Evotec SE is a drug discovery partnership company providing drug discovery solutions to pharmaceutical and biotechnology companies, academic institutions as well as foundations and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes and complications of diabetics, pain and inflammation, oncology and infectious diseases. Its business segments are EVT execute and EVT Innovate. The EVT execute provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of the revenue is generated from the EVT execute segment.
---
0IRF Stock 12 Month Forecast
Average Price Target
€12.80
▲(131.05% Upside)
Technical Analysis
Best Analysts Covering 0IRF
1 Year
1 Year Success Rate
13/22 ratings generated profit
1 Year Average Return
+7.40%
reiterated a sell rating 4 months ago
Copying Falko Friedrichs's trades and holding each position for 1 Year would result in 59.09% of your transactions generating a profit, with an average return of +7.40% per trade.
---